Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
257.75
+7.67 (3.07%)
Jul 11, 2025, 4:00 PM - Market closed
Bio-Rad Laboratories Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$324.25
Upside
+25.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $260 → $245 | Hold | Maintains | $260 → $245 | -4.95% | Jun 9, 2025 |
| UBS | UBS | Strong Buy Maintains $355 → $310 | Strong Buy | Maintains | $355 → $310 | +20.27% | May 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $350 | Strong Buy | Maintains | $400 → $350 | +35.79% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $409 → $392 | Buy | Maintains | $409 → $392 | +52.09% | May 2, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $320 → $270 | Hold | Maintains | $320 → $270 | +4.75% | Apr 17, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $360 → $345 | Hold | Maintains | $360 → $345 | +33.85% | Feb 12, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $481 | Buy | Reiterates | $481 | +86.61% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $369 → $481 | Buy | Maintains | $369 → $481 | +86.61% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $450 | Strong Buy | Maintains | $400 → $450 | +74.59% | Oct 31, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $446 → $469 | Buy | Maintains | $446 → $469 | +81.96% | Oct 31, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $350 → $400 | Hold → Strong Buy | Upgrades | $350 → $400 | +55.19% | Oct 1, 2024 |
| Wells Fargo | Wells Fargo | Hold Initiates $340 | Hold | Initiates | $340 | +31.91% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $401 | Buy | Reiterates | $401 | +55.58% | Aug 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $402 → $401 | Buy | Maintains | $402 → $401 | +55.58% | Aug 2, 2024 |
| Citigroup | Citigroup | Hold Maintains $300 → $350 | Hold | Maintains | $300 → $350 | +35.79% | Aug 2, 2024 |
| UBS | UBS | Strong Buy Maintains $420 → $385 | Strong Buy | Maintains | $420 → $385 | +49.37% | May 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.